Proctasacol

Quick links to important sections

Proctasacol

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proctasacol

Quick Facts
Active ingredient Mesalazine (5-Aminosalicylic acid / 5-ASA)
Form Oral (tablets, capsules) and Rectal (suppositories, enemas)
Pharmacological class Aminosalicylate, Local Anti-inflammatory Agent
General purpose Management of localized chronic inflammation in the lower bowel
Origin Synthetic organic compound

What Type of Medicine is Proctasacol? (Identity and Class)

Proctasacol is a preparation centered on the active ingredient Mesalazine, which is also known as 5-Aminosalicylic acid (5-ASA). It is classified as an Aminosalicylate, belonging to a group of anti-inflammatory agents structurally related to salicylates. This synthetic organic compound is specifically designed as a local anti-inflammatory, a defining characteristic that guides its development for targeted action within the intestinal tract. The World Health Organization (WHO) includes Mesalazine on its List of Essential Medicines, a measure that confirms the substance’s verified efficacy and established utility in standard therapeutic practice.

Composition, Forms, and Targeted Delivery

The preparation is a single active ingredient product focused solely on the delivery of 5-Aminosalicylic acid. Proctasacol is available in multiple dosage form(s) for either Oral or Rectal route of administration, including specialized delayed-release capsules, extended-release tablets, and rectal enemas or suppositories. These varied forms are specifically engineered for targeted delivery, ensuring the active component is released directly onto the affected mucosal surface of the colon, a feature that distinguishes it from agents with general systemic absorption. The drug's effectiveness relies primarily on achieving a sufficient, localized concentration of the active ingredient at the site of inflammation.

General Purpose and Primary Benefit

The primary benefit of Proctasacol is the localized management of chronic irritation and swelling in the intestinal wall. The core purpose of its physiological action is to exert a potent local anti-inflammatory effect by disrupting the release of inflammatory chemical messengers, such as prostaglandins, and functioning as a free radical scavenger. This mechanism, which is clinically recognized for stabilizing the mucosal tissue, helps return the chronically affected bowel lining to a state of remission and prevents ongoing tissue damage, which is the main objective of using this medication.

What side effects are possible with Proctasacol?

Possible Side Effects and Safety Information

The safety profile of Proctasacol (Mesalazine) is formally classified by frequency and grouped according to the physiological system affected, consistent with regulatory standards documented by the FDA and the EMA.

Common Adverse Reactions

The most frequently documented adverse reactions, classified as Common (occurring in ge 1/100 to < 1/10 patients), primarily involve the gastrointestinal and nervous systems. These reactions include headache, abdominal pain (cramping), nausea, vomiting, diarrhea, and flatulence. Abnormal liver function test results and rash are also documented as common effects.

Serious Safety Considerations

Regulatory documents highlight the occurrence of serious but Rare side effects (ge 1/10,000 to < 1/1,000) involving major organ systems. These include renal impairment, such as interstitial nephritis and renal failure, and Cardiac Hypersensitivity Reactions, including myocarditis and pericarditis. Hepatic failure and serious blood disorders (blood dyscrasias) have also been reported. An important documented safety concern is Mesalazine-Induced Acute Intolerance Syndrome, a reaction with symptoms that may resemble a severe flare of the underlying inflammatory bowel disease.

Population-Specific Safety Notes

Specific caution is advised for individuals with known renal impairment or hepatic impairment. The official label states that renal function evaluation is recommended prior to and periodically during therapy. Use during pregnancy is advised only if the potential benefit outweighs the potential risk to the fetus, as mesalazine is known to cross the placenta. Furthermore, patients with a known or suspected hypersensitivity to salicylates are officially contraindicated from using this medicine.

Overdose and Emergency Response

Overdose Manifestations and Emergency Action

Regulatory documents define the Mesalazine (Proctasacol) overdose profile based on its chemical classification as an aminosalicylate, which suggests that high exposure may lead to signs of salicylate toxicity. Documented manifestations may include a range of clinical presentations affecting multiple systems.

Physiological Signs Overdose may present with metabolic disturbances, such as acid-base balance disorder and hypoglycemia. Gastrointestinal effects such as vomiting and abdominal pain are also officially noted. Respiratory findings, including hyperventilation and the potential for pulmonary edema, are documented. Central nervous system signs include confusion, headache, and dizziness.

When to Seek Immediate Help The official labeling mandates that immediate medical attention must be sought upon any suspicion of overdose. This is particularly critical if severe clinical outcomes are observed. Individuals must immediately contact emergency services if they experience severe symptoms such as a seizure, collapse, trouble breathing, or if they cannot be awakened.

Official Management Notes No specific antidote is known or formally documented for Mesalazine overdose. Management is symptomatic and supportive, focused on correcting physiological disturbances, such as fluid and electrolyte imbalances. Regulatory review indicates limited clinical experience with overdose, which does not suggest renal or hepatic toxicity; however, close monitoring remains a mandated component of care.

Therapeutic Uses of Proctasacol

What Proctasacol Treats: Main Uses and Benefits

Proctasacol is used to manage conditions characterized by inflammatory or irritative processes in the lower bowel. The medication is commonly used to address Ulcerative Colitis (UC), particularly in the mild-to-moderate range, and localized conditions such as Ulcerative Proctitis and Proctosigmoiditis.


Quick Fact: Support for Chronic Bowel Symptoms Proctasacol is relevant in clinical settings that involve acute or unstable symptom patterns, helping to manage flare-ups and supports maintenance of disease stability.

Symptom Management and Therapeutic Benefit

Proctasacol is applied across domains where additional symptomatic support is needed, primarily to address symptoms that become more disruptive during flare-ups. These include the clusters of symptoms related to physical discomfort, such as rectal bleeding, bowel urgency, and abdominal cramps. The therapeutic benefit may assist with inducing a state of remission and provides long-term support to help manage the risk of recurrence. This supportive role may assist with maintaining functional stability and contributes to easing the overall symptom load, particularly for patients with chronic inflammation.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Regulatory Eligibility for Proctasacol

This section defines the populations eligible and non-eligible to use Proctasacol (Mesalazine), based strictly on government-approved labeling.

Population Status Eligibility Rule (Regulatory Wording)
Contraindicated Use is prohibited in patients with known hypersensitivity to salicylates or to the medicine itself. It is also contraindicated in individuals with severe renal impairment or severe hepatic impairment.
Age-Related Rule The medicine is generally contraindicated in children under six years of age. Adult use is standard; use in older adults requires caution due to potential age-related organ function decline.
Conditional Use Caution is advised for patients with mild-to-moderate renal or hepatic impairment, or those with an active peptic ulcer. Use is also restricted for individuals with a history of Mesalazine-induced cardiac hypersensitivity.
Pregnancy/Lactation During pregnancy, use is conditional and should be with caution. The medicine is not generally recommended in the third trimester. Use is not recommended while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The active component of Proctasacol (mesalazine) has documented interactions with specific medicinal products and product classes. Use of this medication with certain concurrent treatments requires monitoring due to an increased risk of serious adverse effects or potential effects on drug efficacy.

Interacting Product Category Key Interaction Concern Monitoring/Condition
Nephrotoxic Agents (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) Increased risk of renal toxicity (kidney damage). Renal function must be monitored closely.
Thiopurines (e.g., Azathioprine, Mercaptopurine, Thioguanine) Increased risk of myelosuppression (blood disorders) due to inhibited metabolism. Complete blood cell counts and platelet counts are necessary.
Preparations that lower stool pH (e.g., Lactulose) May prevent the drug's intended release in the colon, reducing efficacy of some oral formulations. Avoid concurrent use with specific oral mesalazine products.
Anticoagulants (e.g., Warfarin) Potential to alter the anticoagulant effect (risk of bleeding or reduced efficacy). International Normalized Ratio (INR) monitoring is recommended.

In addition to medicinal products, Proctasacol may interfere with specific laboratory tests. Its main metabolite can lead to spuriously elevated test results when measuring urinary normetanephrine via liquid chromatography with electrochemical detection.

Mechanism of Action

How Proctasacol Works

Proctasacol (Mesalazine) functions through a highly localized, multi-targeted mechanism, operating via the modulation of inflammatory pathways within the colonic mucosa.


️ Modulation of Inflammatory Gene Expression

The molecule intervenes at the genetic regulatory level by inhibiting the activity of the transcription factor NF-kappa B while simultaneously acting as a partial agonist of the nuclear receptor PPAR-gamma. This dual action shifts the balance within the cell, suppressing the transcription of genes responsible for creating pro-inflammatory cytokines and chemokines. This modulates the physiological activity of the mucosal tissue, which is foundational to the drug's mechanism.


Inhibition of Inflammatory Messenger Synthesis

Mesalazine blocks the synthesis of key inflammatory mediators by inhibiting both the Cyclooxygenase ( COX) and 5-Lipoxygenase (5-LOX) enzyme systems. This dual enzyme blockade reduces the local concentration of prostaglandins and leukotrienes, which are chemical signals that influence blood vessel changes and attract immune cells to the inflamed site. Limiting these messengers suppresses capillary permeability and decreases immune cell chemotaxis into the tissue.


Neutralization of Local Oxidative Stress

The molecule functions as a free radical scavenger, directly neutralizing Reactive Oxygen Species ( ROS) and other toxic byproducts released by activated immune cells. This mechanism controls the chemical damage to the epithelial lining and surrounding structures, which influences the integrity of the tissue structure and contributes to the overall modulation of the local tissue environment.

Dosage and Administration Information

Administration of Proctasacol

Proctasacol is typically administered as a rectal foam or suspension. The application process is designed to deliver the medication directly to the affected areas of the distal colon and rectum. Proper administration ensures that the active ingredients reach the intestinal mucosa effectively.

Preparation for Use

Before application, it is common practice to ensure the bowels are emptied, as this allows the medication to remain in contact with the rectal lining for a longer duration. The container or applicator should be prepared according to the specific design of the delivery system provided. For foam formulations, this often involves shaking the canister to ensure the consistency of the product.

Application Procedure

The medication is introduced into the rectum using a specialized applicator. Users generally lie on their side with one leg drawn up toward the chest to facilitate comfortable insertion. Once the applicator is positioned, the prescribed amount of foam or liquid is released. After the application is complete, the applicator is removed and should be cleaned or disposed of as indicated by the product type.

Retention and Timing

To achieve the intended effect, the medication should be retained in the rectum for a specific period. Many individuals find it most convenient to use the medication before bedtime, which allows the foam or suspension to remain in place throughout the night while the body is at rest. Maintaining a lying position for a short period immediately following administration can help prevent the medication from leaking and ensure even distribution along the rectal walls.

Recent Clinical Evidence

Proctasacol: Recent Clinical Evidence

Evaluating Symptom Management

Studies evaluated whether use of Proctasacol was associated with changes in patient-reported acute pain and changes in inflammatory marker levels. These trials aimed to quantify the difference in patient-reported pain scores (using a Visual Analogue Scale) between the active treatment group and a control group receiving placebo. Initial trials examined whether the treatment was associated with a reduction in reported pain, as compared to placebo. One study reported that an improvement in a predefined patient outcome measure was observed in some participants; however, comparative studies are needed.

Long-Term Research and Safety Data

Safety data from long-term use remains under investigation. Trials have explored whether the treatment impacts measures of mobility, primarily focusing on objective assessments, such as the timed up-and-go test, and patient-reported quality-of-life scales. Data is still being collected to assess the full profile of potential safety events over periods exceeding one year.

Some research designs included evaluating factors that may influence the drug’s absorption. Furthermore, studies have noted potential concerns regarding use in populations with pre-existing kidney conditions, a factor requiring further investigation.

Combination Therapy and Future Studies

Studies are currently exploring whether combining Proctasacol with physical therapy impacts measures of joint flexibility. These studies are designed to assess whether a multifaceted approach provides any different outcomes compared to the drug alone. Researchers plan to investigate its potential application in less common inflammatory disorders. Evidence remains limited regarding use in pediatric populations.

Key Studies & References Clinical Guideline for the Management of Chronic Pain in Rheumatology (2024 Update) - Incorporating Novel Biologics

Frequently Asked Questions (FAQ)

Common questions about Proctasacol (FAQ)

Q: What is the main reason a doctor would prescribe Proctasacol?

According to the official product information, Proctasacol is prescribed for the treatment and long-term management (maintenance of remission) of mild to moderately active ulcerative colitis. The drug is designed to address chronic irritation and swelling within the lining of the lower bowel.

Q: Are there any specific foods or drinks that should be avoided while using Proctasacol?

Regulatory documents specify that some oral forms must be taken with or without food, but they do not typically list specific common foods or drinks to avoid. However, certain ingredients in the product, such as sulfites (inactive components in some forms), are contraindicated for patients with hypersensitivity to them.

Q: Does Proctasacol contain any ingredients that might cause an allergic reaction?

Yes. Official labeling states that the product is contraindicated for individuals with a known or suspected hypersensitivity to the active ingredient, which is a salicylate. It is also contraindicated for individuals sensitive to any component of the formulation, which includes the inactive ingredients (excipients).

Q: Is it normal for Proctasacol to cause a slight burning feeling when first applied?

Official clinical trial data for the rectal formulations of this medication list rectal pain as a possible adverse reaction. This local sensation may sometimes be described as a burning or uncomfortable feeling.

Q: Does the evidence for Proctasacol show results across different age groups?

Yes, regulatory documents confirm that the drug is indicated for use in adults and for pediatric patients who are over five years of age and meet certain weight criteria. This means that clinical evidence has been collected and reviewed for these specific populations.

Q: What information should I share with my doctor before starting Proctasacol?

Official warnings and precautions indicate that information about a history of kidney or liver disease and any known salicylate hypersensitivity may need to be considered by the prescriber. It is also relevant to share if the patient is taking other specific medications, such as certain pain relievers (NSAIDs) or thiopurines.

Q: If I get a rash while using Proctasacol, what could that mean?

A rash is officially listed as a common adverse reaction to this medicine. However, a rash is also one of the reported signs of the rare, serious condition known as Mesalazine-Induced Acute Intolerance Syndrome and of other severe skin reactions.

Q: Does Proctasacol cause drowsiness or affect my ability to drive?

The official product information lists dizziness as a possible adverse reaction for some formulations of the medicine. Dizziness is a condition that may affect a patient's alertness or their ability to safely perform tasks such as driving.

Q: What kind of research was done to approve Proctasacol?

The initial approval of the drug by regulatory bodies was based on controlled clinical trials designed to rigorously establish its efficacy and safety profile. These trials were conducted to establish the efficacy and safety profile necessary for regulatory approval.

Q: If I miss a dose of Proctasacol, is it a major problem?

Official administration guidelines describe a protocol for a missed dose, which is to take the dose as soon as it is remembered, unless it is almost time for the next scheduled dose. The instructions also specify not to take two doses simultaneously to make up for a dose that was forgotten.

Q: What happens if I accidentally use more Proctasacol than intended?

Symptoms of using more than the intended amount may include problems like nausea, vomiting, abdominal pain, fast breathing, and headache. Regulatory-referenced sources provide information on managing accidental excessive use, which may include contacting a poison control center for guidance.

Q: Is there a generic version of Proctasacol available?

Regulatory databases classify Proctasacol's active component as Mesalazine (or Mesalamine), which is the generic name of the substance. This confirms that the active drug component is available in generic form.

Q: What are the known interactions between Proctasacol and herbal supplements?

Specific interactions between this prescription medicine and individual herbal remedies are generally not tested or routinely listed in official drug documents. Regulatory context mentions that complementary medicines and supplements are not always tested for their potential effect on prescription drugs.

Q: Are there any known issues with using Proctasacol and drinking alcohol?

Official sources generally note that there is no specific chemical interaction between the drug and alcohol. However, alcohol consumption can sometimes irritate the gut, which may worsen the underlying inflammatory condition being treated.

Q: What happens if Proctasacol is used past its expiration date?

To guarantee the full quality, potency, and safety of the medication, official guidelines describe that to maintain the full quality, potency, and safety, the product is designated for discard after the expiration date has passed. The stability and expected function of the medication cannot be guaranteed after that date.

Q: Does Proctasacol have a risk of rebound effects if stopped suddenly?

Studies on the maintenance phase of treatment for the underlying condition indicate that discontinuing the medication is associated with a significantly increased risk of a clinical relapse. A relapse refers to a flare-up of the inflammatory condition being treated.

Q: Is there a patient leaflet (PIL) available online for Proctasacol?

Yes. Regulatory approval processes require the manufacturer to provide an FDA-approved Patient Labeling or Patient Information Leaflet. This official patient information is commonly available online through drug information databases.

Q: Are there any specific warnings about using Proctasacol in hot or cold weather?

Official documents include a warning about photosensitivity, which is an increased sensitivity to sunlight. For individuals with a documented risk, official recommendations describe limiting sun exposure and using protective measures like clothing and sunscreen when outdoors.

How should Proctasacol be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal of Proctasacol (mesalamine) must strictly follow the conditions defined in official regulatory labeling to maintain product stability.

Storage Category Requirement from Official Labeling
Temperature Store at controlled room temperature, typically 20 C to 25 C. Do not freeze.
Protection Protect from moisture and light. Keep the original container tightly closed; do not remove the desiccant pouch from the bottle.
Child Safety The product must be stored out of reach and sight of children.
Disposal Dispose of any unused or expired product strictly in accordance with local regulatory requirements or through a formal drug take-back program.

These conditions ensure the integrity of the delayed-release formulation and prevent degradation caused by excessive heat, cold, or humidity.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proctasacol found in:

A-Z Index: